Over the past ten days of trading, Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL), from October 26, 2026 to November 06, 2026 there is a potential Short Squeeze about to happen because of an increase in short volume over the past ten days with very little cover volume.
Because of this the Squeeze Report trend indicator issued a MDGL Short Squeeze.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Short Squeeze Analysis
During the last five days of trading, from November 02, 2026 to November 06, 2026 MDGL had a staggering 1,890,096 shares shorted while trading a total of 5,781,211 shares as show the on MDGL short page.
The last ten days of trading, from October 26, 2026 to November 06, 2026 MDGL had a staggering 2,121,090 shares shorted while trading a total of 6,666,692 shares as show the on MDGL short page.
According to our proprietary algorithm during the last five trading days there were 5 short days, 0 days with no change but 0 cover days. Over the last ten trading days there were 9 short days, 1 days with no change but 0 cover days.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Short Squeeze Result
The short indicator utilizes several factors before determining a result and because of these indications we have placed a short trend indicator of MDGL Short Squeeze.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Short Squeeze Data
Ten Day trading Totals
| Total Shorted Volume | 2,121,090 |
| Total Actual Volume | 6,666,692 |
| Total Volume Discrepancy | 2,761,032 |
Short Trends
| Cover Days | 0 |
| Short Days | 9 |
| No Change Days | 1 |
Averages
| Average Volume Discrepancy | 276,103 |
| Average Short Volume | 212,109 |
| Average Short Percentage | 48% |
The Short Trend Indicator
Squeeze Reports short trend indicator utilizes several different trading factors including, short data, trade data, short analysis and short probability. So become a member of Squeeze Report if you want to to gain access or know more about the short trend indicator and other short trading tools.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Chart
Disclaimer
This article is for the purposes of solicitation subscriptions for Squeeze Report. The company Squeeze Report expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. Squeeze Report or it’s authors do not own any shares of Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) and does not buy, sell, or trade any shares of MDGL. This article does not provide a professional analysis of a (MDGL) financial position. (MDGL) financial position and all other information regarding the featured Company should be verified directly with (MDGL). Squeeze Report has received none USD from N/A for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting N/A ending N/A. Please read our full disclaimer for more detailed information.
